C12N 2502/1329
Cardiomyocytes
C12N2502/1329 (Cardiomyocytes) appears on 41 US grants and 93 published applications in this corpus.
Search patents in C12N- Granted patents
- 41
- Published applications
- 93
- Assignees
- 69
- Inventors
- 185
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 3 |
| 2005 | 0 | 3 |
| 2006 | 0 | 1 |
| 2007 | 1 | 5 |
| 2008 | 0 | 5 |
| 2009 | 0 | 3 |
| 2010 | 0 | 4 |
| 2011 | 3 | 5 |
| 2012 | 2 | 2 |
| 2013 | 1 | 5 |
| 2014 | 6 | 5 |
| 2015 | 3 | 6 |
| 2016 | 1 | 3 |
| 2017 | 4 | 4 |
| 2018 | 2 | 7 |
| 2019 | 2 | 2 |
| 2020 | 3 | 4 |
| 2021 | 1 | 5 |
| 2022 | 3 | 4 |
| 2023 | 2 | 2 |
| 2024 | 1 | 5 |
| 2025 | 3 | 3 |
| 2026 | 2 | 5 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods for the production of cardiac fibroblasts25 Aug 2026US 12,714,728 B2FUJIFILM Cellular Dynamics, Inc.
- Exosomes and micro-ribonucleic acids for tissue regeneration24 Mar 2026US 12,584,127 B2Cedars-Sinai Medical Center
- Cardiac fibroblast derived extracellular matrix23 Sep 2025US 12,419,993 B2Wisconsin Alumni Research Foundation
- Methods for tissue generation29 Jul 2025US 12,371,668 B2
- Ex vivo methods of screening for, and characterizing, cardiac therapeutics using preloaded cardiac tissues22 Apr 2025US 12,282,013 B2Novoheart International Limited
- Method for culturing muscle-derived cells, and culturing device containing muscle-derived cells6 Aug 2026US 2026/0226415 A1IntegriCulture Inc.
- Exosomes and micro-ribonucleic acids for tissue regeneration2 Jul 2026US 2026/0185096 A1Cedars-Sinai Medical Center
- Methods of culturing cardiac cells and use of cells for disease modeling11 Jun 2026US 2026/0159815 A1Rambam Med-Tech Ltd.
- Mesenchymal progenitor cells for enhancing partial reprogramming of target cells12 Mar 2026US 2026/0069635 A1
- Cardiac fibroblast derived extracellular matrix5 Mar 2026US 2026/0061097 A1Wisconsin Alumni Research Foundation
Most cited
By later US patents
- Exosomes and micro-ribonucleic acids for tissue regeneration22US 9,828,603 B2Cedars-Sinai Medical Center · 2017
- Exosomes and micro-ribonucleic acids for tissue regeneration12US 10,457,942 B2Cedars-Sinai Medical Center · 2019
- Blood brain barrier device12US 8,900,865 B2The Invention Science Fund I, LLC · 2014
- Choroid plexus device11US 8,053,220 B2The Invention Science Fund I, LLC · 2011
- Exosomes and micro-ribonucleic acids for tissue regeneration6US 11,220,687 B2Cedars-Sinai Medical Center · 2022